We are advised by NeuroGen that journalists and other readers should disregard the news release, China's First CGRP Targeted Therapy to Enter the NRDL: NeuroGen Officially Launches Ajovy® (fremanezumab), Benefiting the First Cohort of Migraine Patients, issued 18-Nov-2026 over PR Newswire. The release has been withdrawn following a change to the issuer's distribution arrangements.





14 days ago
6 days ago
6 days ago
6 days ago
13 days ago
13 days ago
13 days ago
13 days ago
13 days ago
13 days ago
13 days ago
13 days ago
14 days ago
14 days ago
Contact Us
Notice
Back to Top
Negotiable
Hong Kong Island-
Wan Chai
14 days ago
$65 per Hour
Kowloon-
Tai Kok Tsui
14 days ago
$22,000 per Month
Anywhere in Hong Kong
14 days ago

